Stanford University
Showing 5,001-5,050 of 13,135 Results
-
Kelsea Jackson, PhD
Health Equity Clerkship Program Manager, School of Medicine - Student Affairs
Current Role at StanfordREACH Clerkship Program Manager
-
Peter K. Jackson
Professor of Microbiology and Immunology (Baxter Labs) and of Pathology
Current Research and Scholarly InterestsDr. Jackson’s lab studies how primary cilia organize hormone, metabolite, and growth factor signaling in metabolic tissues and how their disruption causes obesity and diabetes. A second focus is defining the KRAS driven secreted factor networks that rewire the tumor microenvironment in lung and pancreatic cancers to promote immune evasion and therapeutic resistance. This work is revealing new secreted drug targets and combination strategies for precision oncology and metabolic disease.
-
Charlotte D. Jacobs M.D.
Drs. Ben and A. Jess Shenson Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsClinical Interests: general oncology, sarcomas. Research Interests: clinical trials in solid tumors.
-
Lisa Robin Jacobs, MD, MBA
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Jacobs is a child, adolescent & adult psychiatrist in private practice in Menlo Park, CA and an Adjunct Clinical Assistant Professor in the Department of Psychiatry & Behavioral Sciences of the Stanford University School of Medicine. She serves as the Assistant Director of The Pegasus Physician Writers at Stanford and is the Editor at Large of The Pegasus Review. She eared a BA from Cornell University, an MBA from the University of Rochester, and completed medical school at Brown University.
-
Christine Jacobs-Wagner
Dennis Cunningham Professor, Professor of Biology and of Microbiology and Immunology
BioChristine Jacobs-Wagner is a Dennis Cunningham Professor in the Department of Biology and the ChEM-H Institute at Stanford University. She is interested in understanding the fundamental mechanisms and principles by which cells, and, in particular, bacterial cells, are able to multiple. She received her PhD in Biochemistry in 1996 from the University of Liège, Belgium where she unraveled a molecular mechanism by which some bacterial pathogens sense and respond to antibiotics attack to achieve resistance. For this work, she received multiple awards including the 1997 GE & Science Prize for Young Life Scientists. During her postdoctoral work at Stanford Medical School, she demonstrated that bacteria can localize regulatory proteins to specific intracellular regions to control signal transduction and the cell cycle, uncovering a new, unsuspected level of bacterial regulation.
She started her own lab at Yale University in 2001. Over the years, her group made major contributions in the emerging field of bacterial cell biology and provided key molecular insights into the temporal and spatial mechanisms involved in cell morphogenesis, cell polarization, chromosome segregation and cell cycle control. For her distinguished work, she received the Pew Scholars award from the Pew Charitable Trust, the Woman in Cell Biology Junior award from the American Society of Cell Biology and the Eli Lilly award from the American Society of Microbiology. She held the Maxine F. Singer and William H. Fleming professor chairs at Yale. She was elected to the Connecticut academy of Science, the American Academy of Microbiology and the National Academy of Sciences. She has been an investigator of the Howard Hughes Medical Institute since 2008.
Her lab moved to Stanford in 2019. Current research examines the general principles and spatiotemporal mechanisms by which bacterial cells replicate, using Caulobacter crescentus and Escherichia coli as models. Recently, the Jacobs-Wagner lab expanded their interests to the Lyme disease agent Borrelia burgdorferi, revealing unsuspected ways by which this pathogen grows and causes disease -
Gunilla B Jacobson
Technical & Strategic Director, Cyclotron, Rad/Precision Health and Integrated Diagnostics
Current Role at StanfordTechnical and Strategic Director, Cyclotron and Radiochemistry
-
Prasanna Jagannathan
Associate Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsWe study innate immunity and immune regulation of Plasmodium Falciparum malaria in children and pregnant women. Our work focuses on understanding how malaria shapes the immune state in individuals following repeated exposure. We are also testing novel interventions to enhance protective immunity against malaria in children via large, randomized controlled trials. Our work in malaria has been based in Eastern Uganda, where malaria transmission is among the highest in the world.
-
Fereshteh Jahanbani
Sr. Research Scientist Basic Life, Medicine - Med/Immunology & Rheumatology
BioDr. Jahanbani received her PharmD from Tehran University of Medical Sciences (TUMS) and PhD in pharmacology from Iran University of Medical Sciences (IUMS) and her postdoctoral degree from Case Western Reserve University (CWRU) and University of California, Santa Cruz (UCSC). She joined Stanford Center for Genomics and Personalized Medicine in June 2012. Her work is focused on better understanding the etiology of chronic complex conditions and multi-morbidity using multi-omics and precision health approaches. She has been leading ME/CFS related disorders multi-omics study combining the power of both family and population approaches and also cofounded “Research To The People at Stanford Program”.
-
Abhi Jain
Clinical Assistant Professor, Radiology
BioDr. Jain is a neuroradiologist and a Certified Imaging Informatics Professional (CIIP) whose academic work bridges day-to-day neuroradiology practice with imaging informatics and clinically grounded artificial intelligence (AI).
His clinical research interests include quantitative imaging and radiomics in cerebrovascular disease, with particular emphasis on intracerebral hemorrhage (ICH), and imaging biomarkers in the aging brain and neurodegeneration, including limbic-predominant age-related TDP-43 encephalopathy (LATE).
His AI/informatics and quality-improvement interests include large language models (LLMs) for radiology reporting support and clinical decision support, with an emphasis on real-world evaluation and workflow integration.
His education interests focus on modern, technology-enabled neuroradiology teaching, including tailored language models and extended reality (XR; augmented/virtual/mixed reality) approaches to strengthen trainee learning. -
Bhav Jain
MD Student with Scholarly Concentration in Health Services & Policy Research / Surgery, expected graduation Spring 2028
MBA, expected graduation 2028BioBhav Jain is pursuing an MD at the Stanford School of Medicine as a Knight-Hennessy Scholar, Harry S. Truman Scholar, and Samvid Scholar. He graduated from the Massachusetts Institute of Technology (MIT) with a bachelor’s degree in computer science and brain and cognitive sciences. At MIT, he was a Legatum Fellow and received the 40 Under 40 in Cancer Award.
His research on healthcare delivery, social determinants of health, and value-based care has been published in outlets such as Nature Medicine, The Lancet Digital Health, JAMA Oncology, Journal of the National Cancer Institute, American Journal of Public Health, Cancer, Journal of the American College of Surgeons, Journal of General Internal Medicine, and American Journal of Managed Care. While at MIT, he launched The Connected Foundation, which forges intergenerational connections between youth and seniors, and Compass, an SMS platform that streamlines patient intake and scheduling. Most recently, he served as a Fellow at the Boston Public Health Commission to implement interventions aimed at curbing substance abuse and homelessness. As a physician-policymaker, Bhav aspires to create high-value, evidence-based healthcare systems that transform clinical care globally. In particular, he seeks to innovate at both public- and private-sector organizations during his career to improve the quality of and lower the cost of patient care. -
Shaili Jain, MD
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Jain is a board certified psychiatrist with specialty expertise in posttraumatic stress disorder (PTSD), primary and mental health integrated care, and women’s health psychiatry. She is a former health services researcher, affiliated with the National Center for PTSD, who focuses on developing innovative ways to enhance the reach of mental healthcare in underserved populations with PTSD. Her work is widely accredited for elucidating the role of paraprofessionals and peers in the treatment of American veterans with PTSD.
She serves as the Psychiatry representative on Stanford's Executive Committee of the Association of Adjunct Clinical Faculty (AACF) and is also a council member for the Adjunct Clinical Faculty (ACF) council in Stanford's department of psychiatry. She is a distinguished fellow of the American Psychiatric Association.
Dr. Jain is an internationally recognized leader in communicating to the public about trauma and PTSD. Her posts for her Psychology Today blog on PTSD, In the Aftermath of Trauma, have been viewed over 350,000 times. Her acclaimed debut non-fiction trade book, The Unspeakable Mind: Stories of Trauma and Healing from the Frontlines of PTSD Science (Harper, 2019), was nominated for a National Book Award, and her essays and commentaries on trauma and PTSD have been presented by the BBC, CNN, The New York Times, STAT, Newsweek, The Los Angeles Times, The Washington Post, The Atlantic, USA Today, TEDx, public radio, and others -
Sneha Shah Jain MD, MBA
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Sneha S. Jain is a Clinical Assistant Professor of Medicine in the Division of Cardiovascular Medicine at Stanford University, where she specializes in general cardiovascular medicine and preventive cardiology. She co-founded and is the director of GUIDE-AI, which focuses on the development, responsible deployment, and pragmatic evaluation of AI tools to augment healthcare delivery and improve patient outcomes across the healthcare enterprise.
Dr. Jain completed her undergraduate studies in Economics at Duke University, graduating with distinction, before earning her MD from the Johns Hopkins School of Medicine and her MBA from Harvard Business School. She completed internal medicine residency training at Columbia/NewYork-Presbyterian, and fellowship training in cardiovascular medicine at Stanford University.
Dr. Jain serves as an Expert AI Consultant for the Journal of the American College of Cardiology, a member of the AHA Expert Panel for the AI Validation Lab, and Co-Director of the Cross-Sectional Artificial Intelligence Working Group at the American College of Cardiology, where she also serves on the Healthcare Innovation Council. -
Siddhartha Jaiswal
Associate Professor of Pathology
Current Research and Scholarly InterestsWe identified a common disorder of aging called clonal hematopoiesis of indeterminate potential (CHIP). CHIP occurs due to certain somatic mutations in blood stem cells and represents a precursor state for blood cancer, but is also associated with increased risk of cardiovascular disease and death. We hope to understand more about the biology and clinical implications of CHIP using human and model system studies.
-
Sajid Jalil
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioDr. Jalil is a board-certified, fellowship-trained transplant hepatologist (liver doctor) and gastroenterologist at the Stanford Health Care Digestive Health Center in San Jose, California. He is also a clinical associate professor in the Department of Medicine, Division of Gastroenterology and Hepatology, at Stanford University School of Medicine.
Dr. Jalil has extensive experience helping patients with a range of liver- and digestion-related conditions. He specializes in liver transplantation, and his other clinical interests include all forms of hepatitis, cirrhosis of the liver, fatty liver disease, polycystic liver disease, and primary sclerosing cholangitis (swelling and scarring of the bile ducts). He has also volunteered in initiatives to offer free colonoscopy and hepatitis B screenings to underserved ethnic populations.
His research interests include improving mental health by enhancing treatment access for patients with alcohol use disorder causing alcoholic liver disease. He has also studied swallowing problems, liver disease in pregnancy, living liver donation, and the use of artificial intelligence in treating nonalcoholic fatty liver disease and viral hepatitis. In addition, Dr. Jalil wrote a chapter on bile secretion and cholestasis (diminished bile flow) for the fifth edition of Yamada’s Textbook of Gastroenterology.
Dr. Jalil has published in numerous peer-reviewed journals, including World Journal of Hepatology, Liver Transplantation, and the Journal of Clinical Gastroenterology. Additionally, he has served as a reviewer for Pancreatology and as an abstract reviewer for the American Gastroenterological Association (AGA) and the Ohio Chapter of the American College of Physicians. He has presented his research at meetings and conferences worldwide on a range of topics, including the timing of pregnancy after liver transplantation.
Dr. Jalil is an AGA fellow and a member of the American Association for the Study of Liver Diseases, American College of Gastroenterology, and American Society for Gastrointestinal Endoscopy. -
Mehrnaz Nicole Jamali MD
Clinical Associate Professor, Medicine
BioDr. M. Nicole Jamali focus has been in leadership, scientific innovation and streamlining business ventures. Over the past 20 years since graduation from Stanford Internal Medicine Residency, she has held National Positions in AMA as Western Caucus Chair and Appointee to Joint Commission Board. She was reelected to Board of Joint Commission three terms for total of 9 years. She helped rewrite multiple TJC Standards including creation of the Stroke Center of excellence standards and annual "new ideas section of the board". At AMA she authored and passed multiple House rules on variety of subjects affecting thousands of providers and healthcare centers. Her experiences in private practice, group practice, Hospitalist, Insurance Directorship lead to multiple innovative projects including first e-prescription covering both meds and DME in 1999 titled eRemedy,. She then created the first wrong site surgery device which was patented. This project lead to creation of first Transplant App called TPOD which was then simplified to TAPP. It was beta tested in USC and perfected in UCSF Transplant.
Her work with various Insurance companies resulted in streamlined programs and teaching modules improving patient access to health care and millions of dollars in hospital savings of unnecessary admissions.
Her work in creation and streamlining and connecting with local Primary Care providers resulted in rapid expansion of the Hospitalist program of local Hospital by 300%
She is currently interested in Haptic and AI technologies in Medicine and providing 24/7 care to our veterans in remote locations or even the battlefield.
She is currently Clinical Associated Professor and the lead Hospitalist in the new Stanford Cardiovascular Hospitalist Program and enjoys the daily interaction with patients . She truly believes that her mission in life is to be at the bedside of ill patients. She treats them as one of her own family. It is not atypical for her to hand out her personal phone number to make sure they feel safe even when discharged.
